EBS
Emergent Biosolutions Inc
Stock NYSE – Stock Market Prices, News & Analysis
Emergent Biosolutions Inc is a global company specializing in biopharmaceutical products to support immune defenses and public health emergencies.
Emergent Biosolutions Inc
EBS
Emergent Biosolutions Inc is a global company specializing in biopharmaceutical products to support immune defenses and public health emergencies.
Price history of Emergent Biosolutions Inc
Price history of Emergent Biosolutions Inc
Performance & Momentum
Emergent BioSolutions Q2 2025 Results Beat Estimates
Emergent BioSolutions reported Q2 2025 revenue of $140.9 million, surpassing forecasts by $21 million, while reducing its net loss by 96% year-over-year. This strong operational improvement explains the notable 10.36% share price increase, reflecting renewed investor confidence in the company’s financial outlook.
Strategic Analysis
Emergent Biosolutions Inc • 2026
Emergent BioSolutions positions itself as a niche specialist in medical countermeasures and biopharmaceutical products related to public health emergency preparedness. Its business depends more on institutional demand, health security, and public contracts than on a conventional consumer market, which gives it a highly specific profile within healthcare.
- Recognized expertise in emergency preparedness and response products
- Niche positioning with exposure to government and institutional demand
- Potential for a rebound when health-risk perception or strategic stockpiling demand increases
- A highly deteriorated long-term stock market track record, highlighting fragile value creation
- Commercial visibility and revenue recurrence potentially dependent on public orders and regulatory cycles
Momentum appears to be recovering sharply, with recent performance clearly outperforming its still very weak long-term history. Strategically, this suggests a turnaround stock rather than an established quality name: market interest is improving, but the sustainability of the move will depend on operational confirmation and a lasting return of investor confidence.
Similar stocks to Emergent Biosolutions Inc
Recent News
Emergent Biosolutions Inc
Tower Research Capital boosts Emergent BioSolutions stake
11 months agoTower Research Capital LLC (TRC) significantly increased its stake in Emergent BioSolutions Inc. by purchasing 16,345 shares, marking a sharp 7,075.8% rise in the fourth quarter. The sizable investment may signal renewed confidence in Emergent BioSolutions' outlook, especially as the stock fell 7.48% today.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
